Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

OBJECTIVE: This study evaluated the efficacy and safety of flecainide in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) on top of conventional drug therapy. BACKGROUND: CPVT is an inherited arrhythmia syndrome caused by gene mutations that destabilize cardiac ryanodine re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: van der Werf, Christian, Kannankeril, Prince J., Sacher, Frederic, Krahn, Andrew D., Viskin, Sami, Leenhardt, Antoine, Shimizu, Wataru, Sumitomo, Naokata, Fish, Frank A., Bhuiyan, Zahurul A., Willems, Albert R., van der Veen, Maurits J., Watanabe, Hiroshi, Laborderie, Julien, Haïssaguerre, Michel, Knollmann, Björn C., Wilde, Arthur A.M.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3495585/
https://ncbi.nlm.nih.gov/pubmed/21616285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2011.01.026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars